CN110522906B - 多维、多价、前列腺癌特异性肿瘤抗原组装体的制备方法 - Google Patents
多维、多价、前列腺癌特异性肿瘤抗原组装体的制备方法 Download PDFInfo
- Publication number
- CN110522906B CN110522906B CN201910699812.2A CN201910699812A CN110522906B CN 110522906 B CN110522906 B CN 110522906B CN 201910699812 A CN201910699812 A CN 201910699812A CN 110522906 B CN110522906 B CN 110522906B
- Authority
- CN
- China
- Prior art keywords
- prostate cancer
- tumor antigen
- specific tumor
- cancer specific
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001193—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; PAP or PSGR
- A61K39/001195—Prostate specific membrane antigen [PSMA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/884—Vaccine for a specifically defined cancer prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910699812.2A CN110522906B (zh) | 2019-07-31 | 2019-07-31 | 多维、多价、前列腺癌特异性肿瘤抗原组装体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910699812.2A CN110522906B (zh) | 2019-07-31 | 2019-07-31 | 多维、多价、前列腺癌特异性肿瘤抗原组装体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110522906A CN110522906A (zh) | 2019-12-03 |
CN110522906B true CN110522906B (zh) | 2023-04-07 |
Family
ID=68660505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910699812.2A Active CN110522906B (zh) | 2019-07-31 | 2019-07-31 | 多维、多价、前列腺癌特异性肿瘤抗原组装体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110522906B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362263A (zh) * | 2001-01-04 | 2002-08-07 | 北京迪威华宇生物技术有限公司 | 预防和治疗人前列腺癌的重组蛋白疫苗 |
CN1872028A (zh) * | 2006-04-28 | 2006-12-06 | 深圳市人民医院 | 一种免疫磁性纳米微球及其制备方法和用途 |
CN101258166A (zh) * | 2004-04-22 | 2008-09-03 | 阿根西斯公司 | 与steap-1蛋白结合的抗体及其衍生的分子 |
CN105343874A (zh) * | 2015-11-11 | 2016-02-24 | 固安鼎泰海规生物科技有限公司 | 一种前列腺癌核酸疫苗 |
CN106729777A (zh) * | 2017-02-28 | 2017-05-31 | 华南理工大学 | 一种靶向前列腺癌细胞的纳米壳聚糖超声微泡及其制备与应用 |
-
2019
- 2019-07-31 CN CN201910699812.2A patent/CN110522906B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362263A (zh) * | 2001-01-04 | 2002-08-07 | 北京迪威华宇生物技术有限公司 | 预防和治疗人前列腺癌的重组蛋白疫苗 |
CN101258166A (zh) * | 2004-04-22 | 2008-09-03 | 阿根西斯公司 | 与steap-1蛋白结合的抗体及其衍生的分子 |
CN1872028A (zh) * | 2006-04-28 | 2006-12-06 | 深圳市人民医院 | 一种免疫磁性纳米微球及其制备方法和用途 |
CN105343874A (zh) * | 2015-11-11 | 2016-02-24 | 固安鼎泰海规生物科技有限公司 | 一种前列腺癌核酸疫苗 |
CN106729777A (zh) * | 2017-02-28 | 2017-05-31 | 华南理工大学 | 一种靶向前列腺癌细胞的纳米壳聚糖超声微泡及其制备与应用 |
Non-Patent Citations (3)
Title |
---|
Hca-F抗原-HSP70BCG疫苗免疫对小鼠肝癌Hca-F的免疫保护效应;郭连英;《中国老年学杂志》;20171031;第37卷(第20期);全文 * |
徐勇主编.前列腺癌.《前列腺癌》.科学技术文献出版社,2009,第116页第2段,第625-626页. * |
梅兴国主编.微球.《微载体药物递送系统》.华中科技大学出版社,2009,第45-50页. * |
Also Published As
Publication number | Publication date |
---|---|
CN110522906A (zh) | 2019-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112675202A (zh) | 一种基于靶向配基细胞偶联技术的抗肿瘤免疫细胞及其制备方法与应用 | |
CN110613844A (zh) | 一种迷你联合佐剂纳米颗粒及其制备方法和应用 | |
CN109865134A (zh) | 一种杂交纳米肿瘤疫苗的制备方法及其应用 | |
CN111150841A (zh) | 一种主动免疫调控微粒及其制备方法和应用 | |
CN112458054B (zh) | 一种快速扩增体外nk细胞的方法 | |
CN110522906B (zh) | 多维、多价、前列腺癌特异性肿瘤抗原组装体的制备方法 | |
CN113528436A (zh) | 基于淋巴细胞的同源靶向性人工抗原呈递细胞及其构建和应用 | |
CN113403276A (zh) | 抗体功能化的外泌体制剂及其制备方法和应用 | |
CN110759986B (zh) | 一种可逆自组装蛋白的高效制备方法 | |
CN112538462B (zh) | 一种用于nk细胞快速扩增的细胞膜及其应用 | |
CN116359509A (zh) | 一种用于胃癌治疗的肿瘤新抗原筛选方法和新型纳米疫苗的制备方法及应用 | |
CN112972666B (zh) | 个性化基因修饰肿瘤dc疫苗的制备方法 | |
CN113769075B (zh) | 一种原位疫苗及其制备方法 | |
CN108175853A (zh) | 一种肿瘤细胞疫苗及其制备方法 | |
AU1164100A (en) | Use of an enterobacterium protein ompa for specific targeting towards antigen-presenting cells | |
CN110101853B (zh) | 蒲公英型异质纳米囊泡及其应用 | |
CN113940993A (zh) | 一种鲈鱼弹状病毒g2-2m亚单位疫苗及其制备方法 | |
CN106117337B (zh) | 一种特异性肿瘤抗原sf的ctl识别表位肽及其应用 | |
CN106350578A (zh) | Ny-eso-1在微卫星不稳定性肠癌的诊断和治疗中的应用 | |
CN113943689B (zh) | 一种免疫激活性重组乳酸乳球菌的构建及作为肿瘤疫苗和免疫佐剂等方面的应用 | |
CN111407897B (zh) | 基于荧光染料与考马斯亮蓝共结合的亲和素纳米粒及其制备方法和在构建肿瘤疫苗中的应用 | |
CN117402831B (zh) | 规模化、定制化的树突状细胞外泌体在抗肿瘤中的应用 | |
CN117045619B (zh) | 一种共载蜂毒溶瘤肽和腺苷a2ar受体抑制剂的脂质体-聚合物纳米粒及制备和应用 | |
CN117205152B (zh) | 一种药物载体,其制备方法及其在疾病治疗中的应用 | |
CN110643623B (zh) | 人可溶性cd80融合基因转化乳酸菌及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Niu Yuanjie Inventor after: Chen Jiatong Inventor after: Yu Qilin Inventor after: Yang Yang Inventor after: Guo Linpei Inventor after: Cai Qiliang Inventor after: Shang Zhiqun Inventor after: Tang Huiqin Inventor before: Niu Yuanjie Inventor before: Chen Jiatong Inventor before: Lin Pingsheng Inventor before: Yu Qilin Inventor before: Yang Yang Inventor before: Guo Linpei Inventor before: Cai Qiliang Inventor before: Shang Zhiqun Inventor before: Tang Huiqin |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220915 Address after: 300000 No. 23, Pingjiang Road, Hexi District, Tianjin Applicant after: TIANJIN INSTITUTE OF UROLOGY Applicant after: Panru Biotechnology (Tianjin) Co.,Ltd. Address before: No.23 Pingjiang Road, Hexi District, Tianjin 300202 Applicant before: TIANJIN INSTITUTE OF UROLOGY Applicant before: TIANJIN XINPINGTAI BIOTECHNOLOGY CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |